GTC Biotherapeutics (fka GTCB)

[croumagnon]

"GENZ’s right of “first negotiation” comes into play only if GTC has not yet partnered ATryn in the US when the last module of the BLA is submitted. Hence this provision is not a factor in slowing the negotiations going on now."

Interesting! It may not slow down the negotiations but does it not either accelerate them or delay our BLA submission? Also, does it not give the would be partner an edge given that GTCB would be in a pickle with GENZ if they do not seal a partenrship soon?